Open-label Study Investigating of OKN-007 Combined With Temozolomide in Patients With Recurrent Glioblastoma
Clinical trial NCT04388475 · COMPLETED
Trial details
- NCT number
- NCT04388475
- Sponsor
- Oblato, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-12
- Primary completion
- 2024-05-08
- Enrollment
- 57
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.